News

EBCC 2026: Tumour DNA circulating in patients’ blood after pre-surgery treatments predicts whether breast cancer will return

EBCC 2026: Early results from a trial of active surveillance for low-risk DCIS are ‘reassuring’

How inflammation may prime the gut for cancer

FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

Breast cancer hijacks the lung repair system to fuel tumour growth, study finds

Atezolizumab plus chemo after surgery shows benefit for stage III dMMR colon cancer

EBCC 2026: Radiotherapy rather than surgery may help reduce risk of lymphoedema in patients with breast cancer

EBCC 2026: Elinzanetant reduces severity and frequency of hot flushes and night sweats, regardless of type of hormone treatment breast cancer patients receive

New study reveals cellular communication driving chemotherapy resistance in pancreatic cancer

Do psychosocial factors affect cancer risk?

Researchers identify genes for predicting lung cancer recurrence

Advancing colorectal cancer care: Bringing dual immunotherapy and subcutaneous innovation to UK patients